Array BioPharma (Varlitinib) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Array BioPharma (Varlitinib) General Information

Description

A portfolio of full global rights to develop, manufacture and commercialise varlitinib. It is being developed as first-in-class drug for biliary tract, gastric and colorectal cancer, and as best-in-class drug for breast cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 3200 Walnut Street
  • Boulder, CO 80301
  • United States
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Corporate Office
  • 3200 Walnut Street
  • Boulder, CO 80301
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Array BioPharma (Varlitinib) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Array BioPharma (Varlitinib)‘s full profile, request access.

Request a free trial

Array BioPharma (Varlitinib) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Array BioPharma (Varlitinib)‘s full profile, request access.

Request a free trial

Array BioPharma (Varlitinib) FAQs

  • Where is Array BioPharma (Varlitinib) headquartered?

    Array BioPharma (Varlitinib) is headquartered in Boulder, CO.

  • What industry is Array BioPharma (Varlitinib) in?

    Array BioPharma (Varlitinib)’s primary industry is Buildings and Property.

  • Is Array BioPharma (Varlitinib) a private or public company?

    Array BioPharma (Varlitinib) is a Private company.

  • What is the current valuation of Array BioPharma (Varlitinib)?

    The current valuation of Array BioPharma (Varlitinib) is .

  • What is Array BioPharma (Varlitinib)’s current revenue?

    The current revenue for Array BioPharma (Varlitinib) is .

  • Who are Array BioPharma (Varlitinib)’s investors?

    Array BioPharma has invested in Array BioPharma (Varlitinib).

  • When was Array BioPharma (Varlitinib) acquired?

    Array BioPharma (Varlitinib) was acquired on 03-Jan-2018.

  • Who acquired Array BioPharma (Varlitinib)?

    Array BioPharma (Varlitinib) was acquired by ASLAN Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process